Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 26, 2023
Operating activities
Net income before attribution to noncontrolling interests	$ 14,914	$ 22,546
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for allowance for credit losses on accounts and notes receivable	604	513
Depreciation and amortization	17,674	14,721
Deferred income taxes	532	2,031
Stock-based compensation expense	(370)	3,898
Impairment loss	7,554	0
Loss on disposal of property and equipment	688	0
Other	315	496
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	9,084	2,182
Income tax receivable	660	2,822
Inventories	(1,981)	4,330
Prepaid expenses and other current assets	(4,137)	(4,351)
Other assets and liabilities	1,873	71
Accounts payable	(14,406)	(310)
Income and other taxes payable	4,718	(512)
Accrued expenses and other current liabilities	(24,451)	(5,413)
Deferred revenue	(1,284)	(2,236)
Net cash provided by operating activities	11,987	40,788
Investing activities
Purchases of property and equipment	(13,058)	(18,410)
Notes issued	(154)	(976)
Repayments of notes issued	886	1,069
Other	2,174	42
Net cash used in investing activities	(10,152)	(18,275)
Financing activities
Net proceeds of revolving credit facilities	5,300	208,200
Proceeds from exercise of stock options	840	614
Acquisition of Company common stock	0	(209,640)
Dividends paid to common stockholders	(15,068)	(14,603)
Tax payments for equity award issuances	(3,192)	(5,999)
Distributions to noncontrolling interests	(231)	(23)
Principal payments on finance leases	(2,433)	(1,743)
Other	182	(18)
Net cash used in financing activities	(14,602)	(23,212)
Effect of exchange rate changes on cash and cash equivalents	(52)	34
Change in cash and cash equivalents	(12,819)	(665)
Cash and cash equivalents at beginning of period	40,587	47,373
Cash and cash equivalents at end of period	$ 27,768	$ 46,708